AstraZeneca Plc is one of the leading vaccine developers, but interim data released Nov. 23 from trials in Britain and Brazil showed a vastly divergent performance when the vaccine was tested in two different dose combinations.
from Hindustan Times - world https://ift.tt/39OJePR
No comments:
Post a Comment